STABOLY
LIVE

Serial Number

98619367

Owner

Biosynth AG

Attorney

Tara Reedy Sliva

Filing Date

Jun 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

STABOLY Trademark

Serial Number: 98619367

STABOLY is a trademark filed by Biosynth AG on June 26, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Biosynth AG (27 trademarks)

P.O. Box 125
9422 Staad , CH

Entity Type: 03

Trademark Details

Filing Date

June 26, 2024

Registration Date

Not Registered

Published for Opposition

April 1, 2025

Goods & Services

Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for scientific and research use in the field of microbiology and molecular biology; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis research purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms

Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities, for medical treatment purpose and diagnostic use; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties for treating blood disorders, autoimmune diseases, and allergic conditions; Organic chemical preparations and enzymes for medical laboratory diagnostic analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory diagnostic analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); biochemical and organic chemical reagents for clinical diagnostic laboratory use

Filing History

TEAS STATEMENT OF USE RECEIVED
Oct 31, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 27, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 21, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 19, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2025 NWOS
NEW APPLICATION ENTERED
Jun 26, 2024 NWAP